Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.55
Delayed Data
As of Dec 02
 -0.02 / -0.56%
Today’s Change
2.85
Today|||52-Week Range
18.31
-77.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
AssetsCash72.1M63.0M32.5M31.7M
 
 
 
 
 
Short Term Investment Cash5.3M-9.1M-30.5M-739.0K
 
 
 
 
 
Cash & Short Term Investments289.9M254.0M220.1M202.5M
 
 
 
 
 
 
ReceivablesReceivables970.0K847.0K1.1M2.3M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets4.1M6.1M7.5M4.9M
 
 
 
 
 
Current Assets294.9M261.0M228.8M209.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross28.5M------
 
 
Depreciation-17.1M------
 
 
Intangible Assets29.8M29.5M29.3M29.0M
 
 
 
 
 
Other Assets31.2M29.6M31.1M30.9M
 
 
 
 
 
Total Assets337.6M301.9M271.2M251.9M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M2.6M706.0K1.0M
 
 
 
 
 
Accrued Expenses18.7M18.4M14.9M13.2M
 
 
 
 
 
Other Current Liabilities23.1M22.7M19.3M17.6M
 
 
 
 
 
Other Liabilities30.2M25.3M20.0M18.6M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities17.2M16.6M16.5M16.2M
 
 
 
 
 
Total Liabilities47.5M41.9M36.5M34.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity290.1M260.0M234.7M217.1M
 
 
 
 
 
Total Shareholder Equity290.1M260.0M234.7M217.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding98.7M98.7M99.4M101.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.